Keywords: Skeletal, PET/MR, Multiple MyelomaIn this study we evaluated the diagnostic performance of whole-body T2-weighted imaging with uniform 2-point Dixon fat-suppression for the detection of multiple myeloma. Furthermore, we evaluated the added sensitivity, change in disease stage, and change in treatment plan with the sequential addition of DWI and FDG PET. T2-Dixon demonstrated higher sensitivity than both DWI and PET. Adding DWI did not change stage or treatment plan. However, the addition of PET did change the treatment plan in one patient with extra-osseous disease. Whole-body PET-MRI with T2-Dixon is a promising and efficient tool for assessment of multiple myeloma.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords